Evaluation of Safety of Latanoprost Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension
Status: | Archived |
---|---|
Conditions: | High Blood Pressure (Hypertension), Ocular |
Therapuetic Areas: | Cardiology / Vascular Diseases, Ophthalmology |
Healthy: | No |
Age Range: | Any |
Updated: | 7/1/2011 |
Start Date: | November 2010 |
End Date: | September 2011 |
A Clinical Evaluation of Safety of Latanoprost Ophthalmic Solution When Administered Once Daily in Subjects With Open Angle Glaucoma or Ocular Hypertension: an Open Label Study
The purpose of this study is to evaluate the long-term safety of a Latanoprost ophthalmic
solution, a multicenter, open label, non-randomized, uncontrolled, single group assignment,
safety study of subjects with primary open angle glaucoma or ocular hypertension is planned.
Subjects will receive study medication for a period of 24-weeks.
We found this trial at
1
site
Click here to add this to my saved trials